PRINT

Migraine Research Study Application

Principal Investigator Dr. Joel Saper is conducting a clinical research study evaluating an investigational medication for the prevention of migraine headaches.  The study medication is being compared to placebo.  You will have a 40% chance of receiving placebo.  The study medication is given as subcutaneous (under the skin) injections 6 times in the study.  The study is about 35 weeks in duration and requires 15 visits to our Institute in Ann Arbor, MI

To qualify for this study, individuals must:

  • be between 18 and 60 years of age
  • experience > 4 migraine days per month
  • meet other study eligibility criteria

If you qualify, you will receive study-required exams and study medication at no cost to you.  In addition, you may be compensated for your time and travel expenses.

Please complete the following profile and a Research Nurse will contact you.

 

Contact Information
Description of Headache
Questions/Comments For Research Nurse:

The message area below should not be used by individuals who have a clinical circumstance under question which needs direct involvement of a medical professional. Individuals who need direct involvement of a medical professional should contact him/her directly.

Providing this information is voluntary and will be kept as private as possible. Your information will not be sold or shared with other parties without your permission or except as required by law. By submitting this form we have your permission to securely and indefinitely keep your information on file or database and to contact you for possible participation in a future research study. Your information will be removed from the database at any time, just by contacting us.